Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Visual Acuity with Lipid-Based Eye Drops in Contact Lens Wearers
NCT06131476Phase 1Completed
- Sponsor
- Johnson & Johnson
- Start
- Sep 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Investigational lipid eye drops in dry eye syndrome (DED) (2 arms), sponsored by Johnson & Johnson. Primary endpoint: Visual Acuity (logMAR). Started Sep 2020; status: completed.
02
Drugs
Investigational lipid eye drops
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT06131476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06131476.